Literature DB >> 28802681

Activated FGFR3 promotes bone formation via accelerating endochondral ossification in mouse model of distraction osteogenesis.

Yusuke Osawa1, Masaki Matsushita2, Sachi Hasegawa3, Ryusaku Esaki2, Masahito Fujio4, Bisei Ohkawara5, Naoki Ishiguro6, Kinji Ohno5, Hiroshi Kitoh6.   

Abstract

Achondroplasia (ACH) is one of the most common short-limbed skeletal dysplasias caused by gain-of-function mutations in the fibroblast growth factor receptors 3 (FGFR3) gene. Distraction osteogenesis (DO) is a treatment option for short stature in ACH in some countries. Although the patients with ACH usually show faster healing in DO, details of the newly formed bone have not been examined. We have developed a mouse model of DO and analyzed new bone regenerates of the transgenic mice with ACH (Fgfr3ach mice) histologically and morphologically. We established two kinds of DO protocols, the short-DO consisted of 5days of latency period followed by 5days of distraction with a rate of 0.4mm per 24h, and the long-DO consisted of the same latency period followed by 7days of distraction with a rate of 0.3mm per 12h. The callus formation was evaluated radiologically by bone fill score and quantified by micro-CT scan in both protocols. The histomorphometric analysis was performed in the short-DO protocol by various stainings, including Villanueva Goldner, Safranin-O/Fast green, tartrate-resistant acid phosphatase, and type X collagen. Bone fill scores were significantly higher in Fgfr3ach mice than in wild-type mice in both protocols. The individual bone parameters, including bone volume and bone volume/tissue volume, were also significantly higher in Fgfr3ach mice than in wild-type mice in both protocols. The numbers of osteoblasts, as well as osteoclasts, around the trabecular bone were increased in Fgfr3ach mice. Cartilaginous tissues of the distraction region rapidly disappeared in Fgfr3ach mice compared to wild-type mice during the consolidation phase. Similarly, type X collagen-positive cells were markedly decreased in Fgfr3ach mice during the same period. Fgfr3ach mice exhibited accelerated bone regeneration after DO. Accelerated endochondral ossification could contribute to faster healing in Fgfr3ach mice.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Achondroplasia; Bone regeneration; Distraction osteogenesis; Fibroblast growth factor receptors 3; Mice

Mesh:

Substances:

Year:  2017        PMID: 28802681     DOI: 10.1016/j.bone.2017.05.016

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  4 in total

1.  Gain-of-Function of FGFR3 Accelerates Bone Repair Following Ischemic Osteonecrosis in Juvenile Mice.

Authors:  Daisaku Kato; Masaki Matsushita; Yasuhiko Takegami; Kenichi Mishima; Nobuhiro Kamiya; Yusuke Osawa; Shiro Imagama; Hiroshi Kitoh
Journal:  Calcif Tissue Int       Date:  2022-09-07       Impact factor: 4.000

2.  Methyltransferase-like 3-mediated N6-methyladenosine modification of miR-7212-5p drives osteoblast differentiation and fracture healing.

Authors:  Bobin Mi; Yuan Xiong; Chenchen Yan; Lang Chen; Hang Xue; Adriana C Panayi; Liangcong Hu; Yiqiang Hu; Wu Zhou; Faqi Cao; Guohui Liu
Journal:  J Cell Mol Med       Date:  2020-04-19       Impact factor: 5.310

3.  Comparison between the induced membrane technique and distraction osteogenesis in treating segmental bone defects: An experimental study in a rat model.

Authors:  Zhen Shen; Haixiong Lin; Guoqian Chen; Yan Zhang; Zige Li; Ding Li; Lei Xie; Yue Li; Feng Huang; Ziwei Jiang
Journal:  PLoS One       Date:  2019-12-20       Impact factor: 3.240

Review 4.  Comprehensive In Vitro Testing of Calcium Phosphate-Based Bioceramics with Orthopedic and Dentistry Applications.

Authors:  Radu Albulescu; Adrian-Claudiu Popa; Ana-Maria Enciu; Lucian Albulescu; Maria Dudau; Ionela Daniela Popescu; Simona Mihai; Elena Codrici; Sevinci Pop; Andreea-Roxana Lupu; George E Stan; Gina Manda; Cristiana Tanase
Journal:  Materials (Basel)       Date:  2019-11-10       Impact factor: 3.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.